IMvigor130 Archives - Medical Conferences

Exploratory analysis of IMvigor130 trial finds no OS benefit from atezolizumab in subgroups

Presented By

Dr Enrico Grande, MD Anderson Cancer Center, Spain

Trial

Phase 3, IMvigor130

Conference

ASCO 2023

Type

Peer-reviewed article

2 August 2023 09:08

Trial

Phase 3, KEYNOTE-361

Conference

ESMO 2020

Type

Peer-reviewed article

25 November 2020 14:43

Presented By

Dr Enrique Grande, MD Anderson Cancer Centre Madrid, Spain

Trial

IMvigor130

Conference

ESMO 2019

Type

Peer-reviewed article

26 November 2019 21:24